US Patent Issued to Innovate Therapeutics on Sept. 30 for "Controlled release pharmaceutical composition of Selexipag or it's active metabolite" (Indian Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,145, issued on Sept. 30, was assigned to Innovate Therapeutics LLC (Princeton, N.J.).

"Controlled release pharmaceutical composition of Selexipag or it's active metabolite" was invented by Jayendrakumar Dasharathlal Patel (Vijapur, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "A controlled release pharmaceutical dosage form that improve tolerability by reducing incidence of side effect associated with a Selexipag or its active metabolite contained in the dosage form comprising a release rate controlling ingredient in addition to the Selexipag or its active metabolite that govern a release of the Selexipag or its active metabolite from the do...